Mindfulness may ease anxiety for breast cancer patients
NCT ID NCT07221071
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a brief mindfulness program could improve emotional well-being and quality of life in women with early-stage breast cancer. 42 women watched educational videos, listened to guided meditations, and wrote reflections before and after surgery. Researchers measured anxiety, depression, and other outcomes using surveys and finger-prick blood samples.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mindfulness training (educational videos, guided meditations, journaling)
- What this could lead to
- If it works, this could offer a simple, low-cost way to help breast cancer patients feel less anxious and depressed before and after surgery.
- What could go wrong
- This is a small, early study with only 42 participants, so results may not apply to everyone. The mindfulness program is short-term, and benefits may not last long.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
42 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 85 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Females \>20 and \< 85 years of age 2. History of contralateral breast cancer in the past is acceptable 3. Patients seeking second opinion for diagnosis are eligible 4. Clinical AJCC stage 0-III breast cancer 5. Patients who have an in breast tumor recurrence are eligible 6. English Speaking 7. Willing to fill out surveys required for the study 8. Gene mutation carriers are eligible 9. Neoadjuvant therapy patients are eligible Exclusion Criteria: 1. AJCC Stage IV breast cancer 2. Unwilling to fill out surveys for the study 3. Patients with a distant recurrence 4. Patients unaware of their diagnosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Endeavor Health
Evanston, Illinois, 60201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?